CLPT
Clearpoint Neuro Inc
14.80$
+1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +43.0% | +32.5% | -22.3% | -8.3% | +27.5% | +25.1% | +28.4% | -0.4% | +52.5% | +14.4% | +27.0% | +26.1% | +16.6% | +31.0% | +17.8% | |
| – | +3,923.6% | -15.3% | +155.7% | +35.6% | +3.1% | +33.0% | +9.7% | -16.1% | +62.0% | -5.9% | +39.6% | +35.6% | +47.3% | +18.6% | +16.4% | |
| – | +19.2% | +42.4% | -44.3% | -33.2% | +55.4% | +19.2% | +44.2% | +9.8% | +47.9% | +25.4% | +22.0% | +21.6% | +0.6% | +40.5% | +18.7% | |
| – | -25.2% | -62.3% | +82.5% | +12.8% | -40.6% | +34.3% | +7.1% | -17.9% | +21.6% | +66.8% | +98.1% | +17.4% | +7.5% | +5.8% | +12.1% | |
| – | +2.8% | +24.8% | +17.1% | +13.9% | +4.1% | -49.9% | -3.4% | +6.9% | -0.5% | +22.5% | +51.8% | +20.2% | +22.3% | +2.1% | +37.5% | |
| – | -12.5% | -16.0% | +30.8% | +13.5% | -8.9% | +2.6% | +2.1% | -6.0% | +16.7% | +29.2% | +59.7% | +21.9% | +20.8% | +7.8% | +20.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +57.1% | +3.3% | -80.6% | +103.8% | +23.9% | -16.0% | -17.7% | +12.3% | -2.6% | +51.2% | -32.6% | -91.7% | +376.5% | +34.2% | +361.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +57.1% | -13.3% | -57.9% | +166.5% | -38.6% | -14.5% | -30.3% | -92.7% | +1,390.7% | +141.2% | -60.9% | -88.7% | +1,151.6% | -1,567.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.